M3MTHRY +2.83%86 OCF Yield % is 5.96 as of Jun. 27, 2026, which is 303% above its 10-year median of 1.48. GuruFocus rates MTHRY with a GF Score™ of 86/100 and a GF Value™ of $7.68 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 686 Healthcare Providers & Services companies, M3 ranks better than 54.08% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
The historical rank and industry rank for M3's OCF Yield % or its related term are showing as below:
MTHRY'
s OCF Yield % Range Over the Past 10 Years
Min: 0.54 Med: 1.48 Max: 5.96
Current: 5.96
During the past 13 years, the highest OCF Yield % of M3 was 5.96%. The lowest was 0.54%. And the median was 1.48%.
MTHRY's OCF Yield % is ranked better than 54.08% of 686
companies
in the Healthcare Providers & Services industry
Industry Median: 5.555
vs MTHRY: 5.96
M3's OCF Margin % for the quarter that ended in Mar. 2026 was %.
M3 OCF Yield % Explanation
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
M3 OCF Yield % Related Terms
M3 OCF Yield % Historical Data
* Premium members only.
The historical data trend for M3's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, M3's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
M3 OCF Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, M3's OCF Yield % distribution charts can be found below:
* The bar in red indicates where M3's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
M3 (MTHRY) has a OCF Yield % of 5.96 as of Jun. 27, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on M3 and its competitors. This is 303% above median its historical median of 1.48. Over the past decade, M3's OCF Yield % has ranged from 0.54 to 5.96. According to the industry distribution chart, M3 ranks #315 out of 686 companies in the Healthcare Providers & Services industry, placing it in the top 45.9%.
Is M3's OCF Yield % too high?
M3's current OCF Yield % of 5.96 is 303% above median its 10-year median of 1.48. Over the past 10 years, this metric has ranged from a low of 0.54 to a high of 5.96. The Healthcare Providers & Services industry median OCF Yield % is 5.56. M3's value of 5.96 is 7.3% above this industry median. Based on the distribution chart, M3 ranks #315 out of 686 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, M3 has a GF Score™ of 86/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does M3's OCF Yield % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, M3 ranks #315 out of 686 companies for OCF Yield %. This puts M3 in the upper half of its industry. The industry median OCF Yield % is 5.56. M3's value of 5.96 is 7.3% above this benchmark. Historically, M3's own OCF Yield % has ranged from 0.54 to 5.96 over the past decade. While the company's 10-year median is 1.48 vs. the industry median of 5.56, M3 has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Healthcare Providers & Services company?
The median OCF Yield % among Healthcare Providers & Services companies is 5.56, based on 686 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. M3's current OCF Yield % of 5.96 is 7.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on M3 and its competitors. For the Healthcare Providers & Services industry, the median OCF Yield % is 5.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. M3's current OCF Yield % is 5.96, which is 303% above median its own 10-year median of 1.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is M3 stock overvalued right now?
Based on GuruFocus' analysis, M3 (MTHRY) is currently considered Modestly Undervalued. The stock's GF Value™ is $7.68, compared to a current price of $5.45 — trading 29% below its estimated fair value. The current OCF Yield % is 5.96, which is 303% above median its 10-year median of 1.48 and 7.3% above the Healthcare Providers & Services industry median of 5.56. M3's overall GF Score™ is 86/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For M3 (MTHRY), the current OCF Yield % is 5.96 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is M3 (MTHRY) Overvalued in 2026?
Based on GuruFocus' analysis, M3 stock appears to be undervalued.
The current stock price of $5.45 is trading 29% below its estimated GF Value™ of $7.68.
GuruFocus considers M3 to be Modestly Undervalued.
Key valuation signals for MTHRY:
OCF Yield %: 5.96 (303% above median its 10-year median of 1.48)
GF Value™: $7.68 vs. price of $5.45 (29% below fair value)
Industry Position: 7.3% above the Healthcare Providers & Services median (#315 of 686)
No single metric tells the full story. See the MTHRY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
M3 Inc is a Japan-based company engaged in providing medical-related services through internet-based platforms and real-world operations. The company operates six reportable segments: Medical Platform, Evidence Solutions, Career Solutions, Site Solutions, Patient Solutions, and Overseas. Its businesses include online marketing for medical professionals, clinical trial support, human resources services for medical professionals, operational support for medical institutions, and patient support services. The Overseas segment offers similar services internationally, including in the United States, the United Kingdom, China, South Korea, India, France, Germany, and Spain.
86GF Score
Get the complete analysis for MTHRY
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MTHRY has been successfully added to your 
